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Objectives: To investigate the nutritional and haematological status of Sudanese women 
of childbearing age with sickle cell anaemia. Anthropometry and haematology were used 
to asses nutritional status, and health and disease conditions, respectively. 
Subjects and Methods:  Women with steady-state (HbSS, n=39; age =19.0 ± 2.7) without 
(HbAA, n=36; age, 19.8 ± 2.7) sickle cell anaemia were recruited during a routine visit to 
Haematology Clinic, Ibn-Auf Teaching Hospital, Khartoum, Sudan. Ethical approval from 
Ethics Committees of London Metropolitan University, UK, and the University of Khartoum, 
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Medical School and Ministry of Health of Republica of Sudan, and informed consent from 
the participants were obtained.   
Results: The two groups of women lived in similar environmental conditions and ate similar 
diets three times a day. However, despite taking regular meals, the women with sickle 
anaemia were thinner and lighter (p=0.000) and shorter (p=0.002) compared with those 
who do not have the disease. Also, they had higher levels of MCH and White cell count 
(p=0.000), MCH (p=0.003) and platelet (p=0.002) and lower PCV and haemoglobin 
(p=0.000). There was no difference in levels of anthropometric and haematological 
variables between the hydroxyurea treated and untreated sickle cell anaemia patients 
(p>0.05). 
Conclusions: The low anthropometric (height, weight, body mass index) and abnormal 
haematological values in the women with sickle cell anaemia in steady-state are a 
reflection of sustained nutritional insults inflected by the disease and poverty. Tailored 
nutritional counselling/advice must be an integral part of the management of patients with 
sickle cell anaemia. Such advice is particularly vital for women of childbearing because of 
the adverse effects of pre-pregnancy nutritional deficiency on birth outcomes.  
Keywords:  Sudanese Women, childbearing age, sickle cell anaemia, nutrition.  
 
Introduction 
Sickle cell Anaemia (SCA) is an inherited blood disorder. It is transmitted as an autosomal 
recessive gene and characterized by recurrent chronic haemolytic anaemia, vaso-
occlusive crises, and predisposition to infections that impact seriously on morbidity and 
mortality1. SCA is common in Sub-Sahara Africa, Caribbean, Middle East and India and 
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the prevalence is increasing globally because of migration2. The first reporting of the 
presence of HbS gene in Sudan was in by Archibald3. Since then, different studies have 
revealed that Sudan has a high prevalence of SCA, with HbS allele frequency that ranges 
between 0.8% in the Northern and over 30% in Western regions of the country4–6.The high 
HbS allele frequency in the latter region is thought to be due to high level of 
consanguineous marriages (40-45%), the tribal influx from West Africa and endemic 
malaria7,8.  
Despite its genetic simplicity, where SCA is a single substitution base change T>A at 
codon 6 of the β gene, there is significant clinical heterogeneity of the disease probably 
attributable to genetic, epigenetic, nutritional and many environmental factors interacting 
with each other9. Generally, the care for patients with SCA has improved over the years 
due to earlier diagnosis, the widespread use of penicillin prophylaxis, vaccination, folate 
supplementation, and access to comprehensive care programs including blood 
transfusions, and hydroxyurea therapy, impacting significantly on morbidity and 
mortality10–14.  
Nutritional status and growth and development are important indicators of overall health 
and well-being of patients with SCA. Indeed,  patients with sub-optimal nutrition status are 
at increased risk of hospital admission and severe morbidity and mortality. These health 
indicators are often compromised/impaired by a high metabolic rate caused by the 
disease, reduced absorption of essential nutrients and a loss of appetite induced by the 
disease and its treatments. Also, a lack of access to nutrient-dense foods is a major 
problem for sickle cell patients in economically disadvantaged countries and communities.    
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It is widely recognised that maternal nutritional status before pregnancy is one of the main 
determinate factors of pregnancy outcome15–20. Published data are scarce on the 
nutritional status of women of childbearing age with sickle cell anaemia. Indeed, the effect 
of nutritional status before pregnancy on maternal and foetal outcomes has not been 
studied in women with the disease.  
Until recently, it was a rarity to find pregnant women with sickle cell disease in Sudan. 
However, because of improved disease management and the resulting increase in life 
expectancy, their number has increased significantly. Regardless, the country is highly 
underdeveloped with a rudimentary health service system and rampant poverty and 
malnutrition. In this highly patriarchal society, women, young children and individuals with 
chronic diseases tend to bear the brunt of the gross malnutrition and undernutrition.  
Objectives:   
The aim was to investigate the nutritional status and health of Sudanese women of 
childing bearing age with sickle cell anaemia. Anthropometry and haematology were used 
to asses nutritional status, and health and disease conditions, respectively. 
Subjects and methods 
Subjects- Women with steady-state (HbSS, n=39) and without (HbAA n=36)) sickle cell 
anaemia were recruited during a routine visit to the Haematology Clinic, University of 
Khartoum Ibn Auf Teaching Hospital. Inclusion criteria: unmarried women aged 16 -40 
years, volunteered to participate in the study, mental competence to give informed 
consent. Exclusion criteria: sickle cell crisis, acute illness or blood transfusion in the 
previous four months, presence of other chronic diseases, a physical disability which 
impairs access to food or restricts eating, pregnancy. Steady-state is defined absence of 
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sickle cell crisis or acute illness from 4 month before, and up to 2 weeks after blood 
collection for the study. Blood specimen, 5 ml, and detailed anthropometric and 
demographic data, medical history and dietary habits were collected. Ethical approval from 
the Ministry of Health of Sudan, University of Khartoum, Medical School and London 
Metropolitan University, and informed and signed consent from the participants were 
obtained. 
Methods- Demographic data from the patients and medical history from hospital records 
and patients were collected with the use of a questionnaire developed for the study.  
Anthropometry - weight in kilograms and height in centimetres were assessed with a Seca 
Electronic Scale 890 (UNISCALE, Seca, Birmingham, UK) and a heigh-length measuring 
board  (Schorr, Weight and Measure, LLC, Olney, Maryland, USA), respectively.  
Haematological variables - haemoglobin concentration (Hb), packed cell volume (PCV), 
mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), white cell count 
(WBC), and platelets count (PLTS)) - were measured with the use of Sysmex KX-21 N 
Automated Hematology Analyzer (Sysmex Corporation, Kobe, Japan). 
 
Data analysis:  
Data are expressed as mean ± standard deviation (SD) or percentages. Quantitative data 
were tested for normality and homogeneity of variance and subsequently analysed with 
independent t-test  (parametric data) or non-Whitney U test (non-parametric data). 
Categorical (socio-demographic, clinical and laboratory characteristics) data with cell 
frequency of 5 or more were assessed with a Chi-Square test on the contingency platform.  
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When the observed cell count was less than 5, Chi-square and Yate’s Correction of 
Continuity and Fisher's exact test were used under the assumption of independence of 
rows and columns and conditional on the marginal totals. The significance level was set at 
p<0.05.  The data was analysed with IBM SPSS Statistics for Windows, version 26 (IBM 
SPSS Ltd., Woking, Surrey, UK) was used for data analysis. 
Results: 
HbSS versus HbAA  
Anthropometry and Demography  - The anthropometric and demographics characteristics 
of the women with (HbSS) and without (HbAA) sickle cell trait are presented in Table 1.a 
and b. There was no difference in age between the HbSS and HbAA groups  (p>0.05). 
However, the latter group were taller (p=0.002), heavier (p=0.000) and had a higher body 
mass index compared with the former. The HbAA women had higher literacy and 
attendance of tertiary education rates (p=0.000).  
Daily food consumption frequency of the participants is shown in table 2. Most of the sickle 
cell patients and healthy control subjects eat regular breakfast (94.9 vs. 94.4%) and lunch 
(92.3 vs. 94.4%). However, a significant number of the two groups do not consume dinner 
regularly (HbSS, 59% and HbAA 61.1%, p<0.05). 
Clinical -  Of the HbSS, four had liver (4 cm n=2; 2 cm n=2) and one spleen (6 cm) 
enlargemts. None of the patients had a scar for splenectomy. A few of the HbSS patients 
had a past history of painful crisis with haemoloysis and infection.   
Haematology - The haematological variable data of the two groups of women are 
presented in table 3. The women with sickle anaemia compared with the healthy controls 
had lower packed cell volume and haemoglobin concentration (p=0.000) and higher mean 
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corpuscular haemoglobin concentration (MCH, p=0.000),  mean corpuscular volume 
(MCV, p=0.003) and white blood cell (WBC, p=0.000) and platelet (p=0.003) counts. There 
was no difference in lymphocyte and neutrophil counts and systolic and diastolic blood 
pressure between the two groups (p>0.05). 
HbSS (Hydroxyurea treated and Untreated) 
Of the thirty-nine patients who consented to participate in the study, twenty-five were on 
hydroxyurea treatment. Anthropometric, demographic and haematological variable data of 
the hydroxyurea treated and untreated patients at steady-state are presented in table 4. 
Anthropometry and Demography – There was no difference in age, weight, height, body 
mass index and systolic and diastolic blood pressure between the two groups (p>0.05). 
Haematology and blood transfusion history – The hydroxyurea treated and untreated 
patients had a similar history of blood transfusion rates, and comparable levels of 
haemoglobin concentration, packed cell volume and mean corpuscular haemoglobin 
concentration, corpuscular volume and white blood cell, platelet, neutrophil and 
lymphocyte counts (p>0.05). Also, the percentages of patients who were receiving folic 
acid supplementation were not different (treated 100% & untreated 92.8%, p>0.05). 
Discussion 
Consanguineous matrimony, marriage between first and second cousins, is a common 
tradition in all Sudanese tribes.  This is evident from the high percentage of parental blood 
relationship of the HbSS (64%) and HbAA (44%) groups. Consistent with our findings, 
Daak et al 5 have reported a high parental and self-consanguineous marriages in patients 
with sickle cell disease in Western Kordofan State, Sudan.  In this study, although a 
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significant number of the controls and patients were born to parents who are blood 
relatives, the figure was more remarkable in the latter group.  It may be that the social 
stigma associated with the disease makes it very difficult for affected individuals to find a 
suitor (husband/wife) outside the immediate family circle. Regardless, as it is apparent 
from the number of siblings with sickle cell anaemia in the patient group, consanguinity/in-
breeding would be expected to perpetuate and indeed increase the prevalence of the 
disease in Sudan.  
There is an urgent need for comprehensive and well-planned education, social awareness 
and counselling programmes targeted for patients with sickle cell anaemia, and the 
community, particularly in rural areas with deep-rooted traditions, to help reduce 
discrimination and stigma.  It has been reported, in Sudan, the strong predictors of 
negative attitude and discrimination against sickle cell disease are poor knowledge and 
low socio-economic status5. Similar observations have been reported from other Sub-
Sahara African countries21,22. 
Illiteracy is almost a norm in patients with sickle cell disease and they hardly complete high 
school or attend university education. In the current study, the patients without formal 
(illiterate)  and with primary school education accounted for about  61.5%  and only 2 
(5.1%) had tertiary education. Compared with their age and gender-matched classmates, 
an appreciable number of children with the disease are thought to under-perform 
drastically in school23–25 due to disease-caused absences,  neurological abnormalities 




There was no difference in age, ethnicity and the frequency of daily food consumption 
between the two groups of women. However, the SCA group compared with their healthy 
counterparts had lower weight, height and body mass index compared to the control 
women.  These findings are consistent with the results of investigation of previous studies 
29–3418-20.   In contrast to our findings, high BMI and obesity in American children and adults 
with sickle cell anaemia have been reported 35,36. It appears the anthropometric deficits 
commonly observed in patients with the disease in the developing countries can be 
rectified by appropriate nutritional care and clinical management, particularly during 
childhood and adolescence.  
The sickle cell patients who participated in this study were at steady-state and some of 
them had claimed to be on hydroxyurea (35%), folic acid (82%) and omega-3 fatty acids 
(12.8%). However, their haematological profiles, which were abnormal, were significantly 
different from that of the healthy control women. This finding was unexpected since 
hydroxyurea is known to rectify haematological abnormalities in sickle cell disease 37–41. It 
is plausible the patients might have not been taking hydroxyurea as prescribed by their 
physicians because of its side effects (constipation/diarrhoea, hair loss, muscle and joint 
pain, etc), financial difficulties (patient have to pay for their medication in Sudan), inability 
to understand prescription guidelines and/or the drug became unavailable in private and 
hospital pharmacies. Indeed, the haematological data of the hydroxyurea treated and 
untreated patients, which is similar, reveals that the patients were unlikely to have been 
taking the medication as per guidance by pharmacist/doctor. Since most sickle cell 
patients in the country are very poor the government should explore the possibility of 
partially or wholly subsidising hydroxyurea. Also, is vital that doctors check regularly that 
their patients are following the prescription guidelines.  
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Small sample size (more patients who fulfil the inclusion and exclusion criteria could not 
found in the same clinic), failure to collect quantitative nutrients intake data (most of the 
subjects were illiterate and they were unable to record their dietary intakes reliably) and 
failure to perform haemoglobin F tests (lack of laboratory facility) were the main limitations 
of the study. Regardless of these limitations, the study has provided a very good picture of 
the nutritional and health status of Sudanese women of childbearing age with sickle cell 
anaemia.   
Conclusion  
The low anthropometric measures (height, weight, body mass index) and abnormal 
haematological values of the women with sickle cell anaemia in steady-state are a 
reflection of sustained nutrition insults inflected by the disease and poverty. Tailored 
nutritional counselling/advice must be an integral part of the management of patients with 
sickle cell anaemia. Such advice is particularly vital for women of childbearing because of 
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Table 1, a.   Mean age (± S.D) and clinical parameters of the participants 
 







 19.0 ± 2.7 19.8 ± 2.7 NS 
Weight (kg)  
 
39.0 ± 8.9 53.8 ± 11.0 0.001 
Height(cm)  
 
151.0 ± 11.7 158.0 ± 6.7 0.002 
BMI (kg/m2)  
 
17.2 ± 4.3 21.5 ± 4.2 0.001 












Table 1, b    Demographic and clinical variables of the participants 
  





BMI (kg/m2) catigories № (%) № (%) p-Value 
 Under weight (<18.5) 27(69.2) 9 (25.0) 0.001 
 Normal weight (18.5 – 24.9) 11(28.2) 20 (55.5)  0.000 
 Over weight  / obese   >=25 1(2.6) 7(19.4) 0.209 
Education Illiterate & primary school 24 (61.5) 3(8.3) 0.000 
 Middle & high school 13 (33.3) 11(30.5)  
 University 2 (5.1) 22 (61.1) 0.000 
Parental 
relationship 
1st & 2nd degree relatives 25 (64.1) 16 (44.4) 0.037 
 Unrelated 13 (33.3) 20 (55.6) 0.001 
Siblings with SCD Yes 22 (56.4) 3 (8.3) 0.000 
 No 17 (43.6) 33 (91.7) 0.000 
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Table 2. Daily food consumption frequency of the participants 




P- value  
Regular breakfast Yes 37(94.9) 34(94.4) p>0.05 (NS) 
No 2(5.1) 2(5.6)  
Regular Lunch Yes 36(92.3) 34(94.4) NS 
No 3(7.7) 2(5.6)  
Regular Dinner Yes 23(59.0) 14(38.9) NS  
No 16(41.0) 22(61.1)  





Table 3. Mean (± S.D) Haematological characteristics of the participants  
 HbSS (n=39) HbAA (n=36) P- value 
Haemoglobin (g/dL) 9.2 ± 1.6 14.3 ± 1.6  0.000 
PCV (%) 25.1 ± 6.2 37.6 ± 3.3 0.000 
MCV (FL) 88.9 ± 13.5 81.4 ± 5.7 0.003 
MCH (pg) 34.5 ± 3.6 31.0 ± 3.0 0.000 
White cell count (X 103) µL 11.4 ± 4.2 5.9 ± 2.1 0.000 
Neutrophils (%) 51.6 ± 11.3 47.9 ± 9.9 NS 
Lymphocytes (%) 38.8 ± 9.1 41.0 ± 9.5 NS 
Platelets (X 103) µL 409.1± 121.5 328.5 ± 95.6 0.002 
Systolic BP 109.5±10.4 108.5±9.6 NS 
Diastolic BP 67.4±8.4 70.4±8.3 NS 
 № (%) № (%)  
Blood transfusion history YES 32 (82.1) 1(2.9) <0.001 
   NO 7 (17.9) 33(97.1)  
Folic acid supplement 
 
 YES 






















NS = not significant      
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Table 4. Mean (± S.D) anthropometric and haematological characteristics of the 
hydroxyurea treated and untreated (HbSS) groups.   
   Treated  (n=25) Untreated  (n=14) P- value 
Age  18.9 ± 2.4 19.3 ± 3.1 NS 
Weight  39.7 ± 9.7 37.7 ± 7.4 NS 
Height 151.4 ± 13.2  150.3 ± 8.5 NS 
Body mass index  17.50 ± 5.0 16.6 ± 2.5 NS 
Systolic BP 109.0±10.4 110.4 ± 10.5 NS 
Diastolic BP 65.4 ± 8.2 71.1± 7.9 NS 
Hb  (g/dL) 9.2 ± 1.8 9.2  ± 1.1  NS 
PCV (%) 25.0 ± 7.3 25.2 ± 3.8 NS 
MCV (FL) 92.0 ± 6.3 83.4 ± 20.2 NS 
MCH (pg) 35.2 ± 3.5 33.2 ± 3.6 NS 
WCC(X 103)  µL 11.8 ± 4.2 10.7 ± 4.2 NS 
Neutrophils (%) 51.4 ± 10.4 52.0 ± 13.2 NS 
Lymphocytes (%) 37.7 ± 8.4 40.6 ± 10.5 NS 
Platelets (X 103)  µL 412.2 ± 130.2 403 ± 108.8 NS 
 № (%) № (%)  
History of Blood transfusion   Yes 
                                                    No                    
20 (80) 12 (85.7) NS  
5 (20) 2 (14.2) NS 
Folic acid supplement              Yes 
                                                    No 
25 (100) 13 (92.8) NS 
0 (0) 1 (7.2) NS 
NS= not significant     
